Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062264 · ClinicalTrials.gov registry record · NA
Patient Portal Flu Vaccine Reminders (RCT 6)
A NA study of Influenza and Respiratory Tract Infections, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 22,233
- Enrollment target
- 1
- Study location
NCT06062264 is a NA study of Influenza and Respiratory Tract Infections that has completed, run by University of California, Los Angeles. The registered enrollment target is 22,233 participants, below the 36,661-participant average among 156 other Influenza trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06062264, a NA study of Influenza and Respiratory Tract Infections, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 22,233 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial is taking place in Los Angeles, CA at 21 clinics within the UCLA Health System. The study design is a 3 arm randomized trial. Patients will be randomized into 1) receiving portal based reminder messages with a video from their PCP encouraging them to receive the influenza vaccine, 2) portal-based reminder messages with an infographic with the image of their PCP encouraging them to receive the influenza vaccine, or 3) the control group. Patients randomized to the intervention arms will receive reminders if they are due for influenza vaccine. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and \>65 yrs. (63%). The investigators will assess the effectiveness of MyChart R/R video messages and infographic messages as compared to the standard of care control (Health system messages).
Conditions Studied
Interventions
- BEHAVIORAL Portal-based Video Message
- BEHAVIORAL Portal-based Infographic Message
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,233 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06062264
The ClinicalTrials.gov registry entry for NCT06062264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22,233 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,661-participant average among 156 other Influenza trials with a reported enrollment target (39% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Portal-based Video Message is the first listed.
NCT06062264 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06062264 about?
NCT06062264 is a clinical study titled "Patient Portal Flu Vaccine Reminders (RCT 6)". This trial is taking place in Los Angeles, CA at 21 clinics within the UCLA Health System. The study design is a 3 arm randomized trial. Patients will be randomized into 1) receiving portal based reminder messages with a video from their PCP encouraging them to receive the influenza vaccine, 2) por...
What is the current status of trial NCT06062264?
This trial is currently completed. It is a NA study. The enrollment target is 22,233 participants. The study started on 2023-10-03. Estimated completion is 2024-04-01.
What conditions does trial NCT06062264 study?
This clinical trial studies the following conditions: Influenza, Respiratory Tract Infections.
What interventions are being tested in trial NCT06062264?
The interventions under investigation include: Portal-based Video Message (BEHAVIORAL), Portal-based Infographic Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT06062264?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06062264 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.